Learn, Analyse & Invest
only with
only with
+91
Download Orca
Astec Lifesciences Ltd.
Astec Lifesciences
₹ 0.00
0.00 (0.00)%
NSE
BSE
Chemicals
Small-cap - With a market cap of ₹18.60 Cr.
| EX-Date | Purpose |
|---|---|
| 30 04 2021 | Audited Results & Final Dividend |
| 28 07 2021 | Quarterly Results |
| 27 10 2021 | Quarterly Results |
| 25 01 2022 | Quarterly Results |
| 02 05 2022 | Audited Results & Final Dividend |
| 25 07 2022 | Quarterly Results |
| 28 10 2022 | Quarterly Results |
| 30 01 2023 | Quarterly Results Inter alia, the Board may also consider and approve issuance of Debentures or debt securities upto such limit as may be deemed appropriate and approved by the Board, subject to such other approval(s) as may be applicable. |
| 02 05 2023 | Audited Results & Final Dividend |
| 27 07 2023 | Quarterly Results |
| 27 10 2023 | Quarterly Results & Inter alia, may also consider and approve enhancement in the existing limit of issuance of Debenture(s) or Debt Securities upto such limit as may be deemed appropriate by the Board, subject to such other approval(s) as may be applicable. |
| 25 01 2024 | Quarterly Results |
| 25 10 2024 | Quarterly Results |
| 27 01 2025 | Quarterly Results |
| 23 04 2025 | Quarterly Results & Audited Results |
| 24 06 2025 | Inter alia, to consider and approve the proposal of fund raising by way of Equity Shares or any other securities through appropriate mode including rights issue, as may be permitted under applicable law and as may be decided by the Board, subject to such regulatory/statutory approvals as may be required |
| 30 06 2025 | Right Issue of Equity Shares |
News
No News data available
